DETROIT – Robert A. Chapman, M.D., director of the Josephine Ford Cancer Institute at Henry Ford Health System, has been appointed to a three-year term on the Michigan Cancer Consortium board of directors.
The Michigan Cancer Consortium is a state-wide organization supported by the Michigan Department of Community Health. Its focus is to reduce the human and economic burden of cancer. Membership consists of more than 120 health care organizations across the state.
Dr. Chapman, of Bloomfield Hills, is an expert in lung cancer. He previously secured a competitive Medicare grant to study disparities in cancer care in the African American population. Henry Ford was awarded $5.2 million in national funding to determine if working to overcome barriers such as transportation, assistance with co-pays and facilitating cancer screenings, diagnosis and treatment, could reduce disparities in cancer death rates among African Americans.
Dr. Chapman heads the Division of Hematology/Oncology at Henry Ford Hospital. He formerly chaired a National Cancer Institute Scientific Review Committee responsible for making research funding recommendations, and served on the American Cancer Society and the governing board of the Southwest Oncology Group.
He received his medical degree from Cornell University Medical School, and completed his internal medicine residency at Henry Ford Health System and his medical oncology training at the Memorial Sloan Kettering Cancer Center.
